Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$79.5M Sell
225,913
-26,547
-11% -$9.46M 0.62% 26
2025
Q4
$82.6M Buy
252,460
+6,245
+3% +$1.98M 0.59% 29
2025
Q3
$69.5M Buy
246,215
+9,223
+4% +$2.67M 0.5% 30
2025
Q2
$66.2M Buy
236,992
+22,706
+11% +$6.43M 0.53% 30
2025
Q1
$66.8M Sell
214,286
-24,052
-10% -$7.1M 0.61% 21
2024
Q4
$62.1M Sell
238,338
-8,356
-3% -$2.48M 0.5% 31
2024
Q3
$79.5M Sell
246,694
-30,375
-11% -$9.94M 0.56% 23
2024
Q2
$86.6M Sell
277,069
-11,710
-4% -$3.44M 0.61% 19
2024
Q1
$82.1M Buy
288,779
+3,839
+1% +$1.12M 0.58% 19
2023
Q4
$82.1M Sell
284,940
-14,304
-5% -$3.9M 0.62% 20
2023
Q3
$80.4M Buy
299,244
+7,542
+3% +$1.88M 0.69% 16
2023
Q2
$64.8M Buy
291,702
+27,176
+10% +$6.31M 0.51% 22
2023
Q1
$63.9M Buy
264,526
+23,745
+10% +$5.83M 0.54% 20
2022
Q4
$63.2M Sell
240,781
-42,846
-15% -$11.5M 0.56% 18
2022
Q3
$63.9M Buy
283,627
+388
+0.1% +$94K 0.59% 17
2022
Q2
$68.9M Sell
283,239
-34,851
-11% -$8.54M 0.54% 19
2022
Q1
$76.9M Sell
318,090
-41,356
-12% -$9.5M 0.46% 28
2021
Q4
$80.9M Buy
359,446
+47,642
+15% +$10.1M 0.42% 34
2021
Q3
$66.3M Buy
311,804
+4,679
+2% +$1.08M 0.4% 28
2021
Q2
$74.9M Buy
307,125
+24,963
+9% +$6.14M 0.44% 24
2021
Q1
$70.2M Sell
282,162
-28,299
-9% -$6.75M 0.46% 24
2020
Q4
$71.4M Buy
310,461
+23,368
+8% +$5.39M 0.45% 25
2020
Q3
$73M Sell
287,093
-26,880
-9% -$6.66M 0.53% 17
2020
Q2
$74.1M Buy
313,973
+52,267
+20% +$11.9M 0.57% 15
2020
Q1
$53.1M Sell
261,706
-70,834
-21% -$15.5M 0.53% 16
2019
Q4
$80.2M Buy
332,540
+30,153
+10% +$6.65M 0.6% 12
2019
Q3
$58.5M Sell
302,387
-422
-0.1% -$81K 0.47% 20
2019
Q2
$55.8M Sell
302,809
-11,312
-4% -$2.03M 0.45% 24
2019
Q1
$59.7M Buy
314,121
+14,785
+5% +$2.82M 0.49% 20
2018
Q4
$58.3M Sell
299,336
-53,937
-15% -$10.5M 0.49% 18
2018
Q3
$73.2M Sell
353,273
-30,674
-8% -$6.05M 0.48% 14
2018
Q2
$70.9M Sell
383,947
-310,604
-45% -$54.9M 0.47% 15
2018
Q1
$118M Sell
694,551
-39,715
-5% -$7.29M 0.29% 26
2017
Q4
$128M Buy
734,266
+10,980
+2% +$1.94M 0.3% 18
2017
Q3
$135M Sell
723,286
-65,935
-8% -$11.7M 0.32% 16
2017
Q2
$136M Buy
789,221
+129,209
+20% +$21M 0.36% 9
2017
Q1
$108M Sell
660,012
-65,347
-9% -$10.9M 0.29% 20
2016
Q4
$106M Buy
725,359
+49,543
+7% +$7.46M 0.3% 26
2016
Q3
$113M Buy
675,816
+1,415
+0.2% +$239K 0.35% 16
2016
Q2
$103M Sell
674,401
-45,625
-6% -$7.09M 0.32% 24
2016
Q1
$108M Sell
720,026
-98,731
-12% -$14.7M 0.34% 15
2015
Q4
$133M Sell
818,757
-243,928
-23% -$38.3M 0.39% 10
2015
Q3
$147M Sell
1,062,685
-249,979
-19% -$39.4M 0.45% 9
2015
Q2
$202M Buy
1,312,664
+21,124
+2% +$3.38M 0.5% 7
2015
Q1
$206M Buy
1,291,540
+314,424
+32% +$49.5M 0.49% 8
2014
Q4
$156M Buy
977,116
+15,174
+2% +$2.36M 0.39% 8
2014
Q3
$135M Buy
961,942
+176,863
+23% +$23.1M 0.32% 15
2014
Q2
$92.9M Sell
785,079
-7,260
-0.9% -$840K 0.24% 38
2014
Q1
$97.7M Buy
792,339
+8,517
+1% +$1.03M 0.28% 27
2013
Q4
$89.5M Sell
783,822
-93,657
-11% -$10.7M 0.27% 27
2013
Q3
$98.2M Buy
877,479
+127,994
+17% +$13.9M 0.35% 17
2013
Q2
$73.9M Buy
+749,485
New +$77.8M 0.31% 21

Other funds holding AMGN

Guggenheim Capital's AMGN Position: Q1 2026 in Review

Guggenheim Capital reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $9.46M and leaving 225,913 shares worth $79.5M. The position accounts for 0.62% of the portfolio, ranked #26.

Guggenheim Capital first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $206M in Q1 2015. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Guggenheim Capital held 225,913 shares of Amgen worth $79.5M as of Q1 2026.
  • Guggenheim Capital sold 26,547 Amgen shares in Q1 2026, an estimated $9.46M.
  • Amgen made up 0.62% of Guggenheim Capital's portfolio in Q1 2026, its #26 holding.
  • Guggenheim Capital first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Guggenheim Capital's Amgen position peaked at $206M in Q1 2015.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.